Ghrelin
- 1 April 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 239 (4) , 464-474
- https://doi.org/10.1097/01.sla.0000118561.54919.61
Abstract
Ghrelin is a novel gastric hormone recognized in 1999 as a mediator of growth hormone release. Since growth hormone is anabolic, an important function of ghrelin may be to coordinate energy needs with the growth process. Newly discovered biologic roles of ghrelin imply that it may have other important physiological functions as well. This is a review of recent clinically relevant, yet less well-known, physiologic actions of ghrelin. Ghrelin has profound orexigenic, adipogenic, and somatotrophic properties, increasing food intake and body weight. Secreted predominantly from the stomach, ghrelin is the natural ligand for the growth hormone secretagogue receptor in the pituitary gland, thus fulfilling criteria of a brain-gut peptide. The brain-gut axis is the effector of anabolism by regulating growth, feeding, and metabolism via vagal afferents mediating ghrelin signaling. However, the wide tissue distribution of ghrelin suggests that it may have other functions as well. Systematic literature review of all PubMed citations between 1999 and August 2003 focusing on clinically relevant biochemical and physiological characteristics of ghrelin. Ghrelin is an important component of an integrated regulatory system of growth and metabolism acting via the vagus nerve, and is implicated in a variety of altered energy states such as obesity, eating disorders, neoplasia, and cachexia. It also enhances immune responses and potentially down-regulates anti-inflammatory molecules. Ghrelin's role as a brain-gut peptide emphasizes the significance of afferent vagal fibers as a major pathway to the brain, serving the purpose of maintaining physiologic homeostasis. The discovery of ghrelin has increased our understanding of feeding regulation, nutritional homeostasis, and metabolic processes. Further characterization of ghrelin's functions will likely generate new pharmacological approaches to diagnose and treat different disease entities including those related to the over-nutrition of obesity and the catabolic response to surgical trauma.Keywords
This publication has 115 references indexed in Scilit:
- Structural Divergence of Human GhrelinJournal of Biological Chemistry, 2003
- Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammationNature, 2002
- Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKTThe Journal of cell biology, 2002
- Inhibition of pancreatic protein secretion by ghrelin in the ratThe Journal of Physiology, 2001
- Ghrelin Acts in the Central Nervous System to Stimulate Gastric Acid SecretionBiochemical and Biophysical Research Communications, 2001
- Central Effects of a Novel Acylated Peptide, Ghrelin, on Growth Hormone Release in RatsBiochemical and Biophysical Research Communications, 2000
- Purification and Characterization of Rat des-Gln14-Ghrelin, a Second Endogenous Ligand for the Growth Hormone Secretagogue ReceptorJournal of Biological Chemistry, 2000
- Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathyThe Lancet, 1998
- Behavioral effects of vagotomy in humansJournal of the Autonomic Nervous System, 1983
- VAGOTOMY FOR TREATMENT OF SEVERE OBESITYThe Lancet, 1978